2009Jiangsu Medical JournalRequires access

Expression and clinical significance of CD133 in hepatocellular carcinoma

Feng Chen

Open publisher page 0 citations

Abstract

Objective To study the expression and clinical significance of cancer stem cell marker CD133 in hepatocellular cancer(HCC) tissues. Methods The expressiones of CD133 mRNAs extracted from human HCC tissues and paracarcinoma tissues(PT) of 25 patients were detected by RT-PCR.The relationship between CD133 and clinicopathological index was analyzed. Results The positive rate of the CD133 mRNA expression in HCC tissues was 72.0%,which was significantly higher than 4.0% in PT(P0.01).The expression of CD133 mRNA was correlated with tumor size and the expression of AFP(P0.05),but not with sex,age and tumor differentiation (P0.05).Conclusion The expression of cancer stem cell marker CD133 is related to tumorigenesis of HCC and the expression of AFP. CD133 may be a valuable marker for diagnosing and predicting the prognosis of HCC.

About this research paper

What this paper is about

Objective To study the expression and clinical significance of cancer stem cell marker CD133 in hepatocellular cancer(HCC) tissues. Methods The expressiones of CD133 mRNAs extracted from human HCC tissues and paracarcinoma tissues(PT) of 25 patients were detected by RT-PCR.The relationship between CD133 and clinicopathological index was analyzed. Results The positive rate of the CD133 mRNA expression in HCC tissues was 72.0%,which was significantly higher than 4.0% in PT(P0.01).The expression of CD133 mRNA was correlated with tumor size and the expression of AFP(P0.05),but not with sex,age and tumor differentiation (P0.05).Conclusion The expression of cancer stem cell marker CD133 is related to tumorigenesis of HCC and the expression of AFP. CD133 may be a valuable marker for diagnosing and predicting the prognosis of HCC.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the expression and clinical significance of cancer stem cell marker CD133 in hepatocellular cancer(HCC) tissues. Methods The expressiones of CD133 mRNAs extracted from human HCC tissues and paracarcinoma tissues(PT) of 25 patients were detected by RT-PCR.The relationship between CD133 and clinicopathological index was analyzed. Results The positive rate of the CD133 mRNA expression in HCC tissues was 72.0%,which was significantly higher than 4.0% in PT(P0.01).The expression of CD133 mRNA was correlated with tumor size and the expression of AFP(P0.05),but not with sex,age and tumor differentiation (P0.05).Conclusion The expression of cancer stem cell marker CD133 is related to tumorigenesis of HCC and the expression of AFP. CD133 may be a valuable marker for diagnosing and predicting the prognosis of HCC.

Key concepts: Hepatocellular carcinoma, Carcinogenesis, Clinical significance, Messenger RNA, Cancer stem cell, Pathology, Cancer, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression and clinical significance of CD133 in hepatocellular carcinoma — Research Paper | ScholarLens